Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 26Recruiting 14Unknown 11Not yet recruiting 6Active not recruiting 4Terminated 3Withdrawn 1Suspended 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Genitourinary 5Gastrointestinal 5Thoracic 3Lymphoid 3CNS 3Other 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Lymphoma 369Lymphoma, Non-Hodgkin 346Leukemia, Lymphocytic, Chronic, B-Cell 321Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Lymphoma, Large B-Cell, Diffuse 244Lymphoma, Follicular 236Leukemia 197Hodgkin Disease 170Lymphoma, Mantle-Cell 164Leukemia, Myeloid, Acute 160Multiple Myeloma 134Myelodysplastic Syndromes 130Recurrence 125Burkitt Lymphoma 123Lymphoma, B-Cell, Marginal Zone 120Lymphoma, T-Cell, Cutaneous 92Mycosis Fungoides 82Neoplasms 81Lymphoma, B-Cell 81Waldenstrom Macroglobulinemia 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 70Sezary Syndrome 67Lymphoma, Large-Cell, Immunoblastic 65Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Large-Cell, Anaplastic 54Neoplasms, Plasma Cell 52Myeloproliferative Disorders 52Primary Myelofibrosis 46Hematologic Neoplasms 44Blast Crisis 43

Interventions

secukinumab 1Exercise 1Andrographis paniculata extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Motor Activity × Lymphoid × Clear all
NCT03850171 2023-02-27

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Insel Gruppe AG, University Hospital Bern

Phase NA Terminated
57 enrolled
BreastLymphoid

Breast Diseases, Breast Neoplasms, Heart Failure, Lymphoma, Motor Activity, Ventricular Dysfunction, Left, Cardiotoxicity

NCT01805791 2020-01-02

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Hutchmed

Phase 3 Terminated
201 enrolled 15 charts
Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

NCT00584740 2015-03-31

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Novartis

Phase 2 Terminated
59 enrolled 13 charts
Lymphoid

Crohn Disease, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡